Crossmark

<i>In Vitro</i> Activity Analysis of a New Polymyxin, SPR741, Tested in Combination with Antimicrobial Agents against a Challenge Set of <i>Enterobacteriaceae</i> , Including Molecularly Characterized Strains

Crossref DOI link: https://doi.org/10.1128/AAC.00742-20

Published Print: 2020-12-16

Update policy: https://doi.org/10.1128/asmj-crossmark-policy-page

Authors

Mendes, Rodrigo E. https://orcid.org/0000-0002-8648-1137
Rhomberg, Paul R. https://orcid.org/0000-0001-6798-7653
Lister, Troy

Cotroneo, Nicole https://orcid.org/0000-0002-5267-4176
Parr, Thomas R.

Castanheira, Mariana https://orcid.org/0000-0003-0126-1782
Funding

Funding for this research was provided by:

Office of the Assistant Secretary of Defense for Health Affairs (W81XWH-16-2-0019)

Spero Therapeutics

HHS | Biomedical Advanced Research and Development Authority (IDSEP160030)
License Information

Text and Data Mining valid from 2020-12-16
More Information

Publication History

Received: 2020-04-16

Accepted: 2020-10-09

Published: 2020-12-16

Document is current

Any future updates will be listed below